Kevin Lind

Mr. Lind has over 20 years of experience in the life sciences industry. Prior to joining Longboard Pharmaceuticals, Mr. Lind served as Executive Vice President and Chief Financial Officer of Arena Pharmaceuticals from June 2016 to February 2020. Prior to Arena, Mr. Lind was a Principal focused on healthcare at TPG Special Situations Partners, a global investment firm, from January 2009 to June 2016. Mr. Lind was a member of the TPG Pharma Partners effort at TPG-Axon, a global investment firm, from 2006 to 2008. He served in various capacities as a healthcare investment banker at Lehman Brothers, Inc., a former global financial services firm, from 1998 to 2002 and 2004 to 2006. Mr. Lind currently serves on the board of Ceek Women’s Health, a medical device company focused on creating innovative products for more comfortable gynecological exams and procedures. Mr. Lind received a B.S. from Stanford University in Biological Sciences and an M.B.A. from UCLA Anderson School of Management.